These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 7595199)

  • 21. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice.
    Davidson NJ; Hudak SA; Lesley RE; Menon S; Leach MW; Rennick DM
    J Immunol; 1998 Sep; 161(6):3143-9. PubMed ID: 9743382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
    Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
    J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease.
    Kanai T; Watanabe M; Okazawa A; Sato T; Yamazaki M; Okamoto S; Ishii H; Totsuka T; Iiyama R; Okamoto R; Ikeda M; Kurimoto M; Takeda K; Akira S; Hibi T
    Gastroenterology; 2001 Oct; 121(4):875-88. PubMed ID: 11606501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice.
    Zhao Y; Zhang S; Jiang L; Jiang J; Liu H
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1775-80. PubMed ID: 20136961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.
    Zuo L; Yuan KT; Yu L; Meng QH; Chung PC; Yang DH
    World J Gastroenterol; 2014 Dec; 20(48):18316-29. PubMed ID: 25561798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models.
    Maerten P; Shen C; Colpaert S; Liu Z; Bullens DA; van Assche G; Penninckx F; Geboes K; Vanham G; Rutgeerts P; Ceuppens JL
    Clin Exp Immunol; 2004 Feb; 135(2):310-7. PubMed ID: 14738461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice.
    Camoglio L; te Velde AA; de Boer A; ten Kate FJ; Kopf M; van Deventer SJ
    Eur J Immunol; 2000 May; 30(5):1486-95. PubMed ID: 10820397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in mice.
    Stallmach A; Wittig B; Giese T; Pfister K; Hoffmann JC; Bulfone-Paus S; Kunzendorf U; Meuer SC; Zeitz M
    Gastroenterology; 1999 Oct; 117(4):866-76. PubMed ID: 10500069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-(3', 4'-dimethoxycinnamonyl) anthranilic acid alleviated experimental colitis by inhibiting autoimmune response and inducing CD4+ CD25+ regulatory T cells production.
    Wen Q; Zhou L; Chen H; Zhang Y
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1330-8. PubMed ID: 23663055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
    Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
    Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice.
    Pfister K; Wittig BM; Jüngling B; Ecker KW; Barth S; Huhn M; Sasse S; Engert A; Mueller-Molaian I; Diehl V; Zeitz M; Stallmach A
    Int J Colorectal Dis; 2002 Mar; 17(2):77-84. PubMed ID: 12014425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diosmetin regulates intestinal immune balance by inhibiting PI3K/AKT signaling to relieve 2, 4, 6-trinitrobenzene sulfonic acid-induced Crohn's disease-like colitis in mice].
    Yang Z; Zhao T; Cheng Y; Zhou Y; Li Y; Wang X; Zhang X; Zuo L; Ge S
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):474-482. PubMed ID: 37087594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Andrographolide sulfonate ameliorates chronic colitis induced by TNBS in mice via decreasing inflammation and fibrosis.
    Gao J; Cui J; Zhong H; Li Y; Liu W; Jiao C; Gao J; Jiang C; Guo W; Xu Q
    Int Immunopharmacol; 2020 Jun; 83():106426. PubMed ID: 32220806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis.
    Dohi T; Fujihashi K; Kiyono H; Elson CO; McGhee JR
    Gastroenterology; 2000 Sep; 119(3):724-33. PubMed ID: 10982767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.
    Guan Q; Ma Y; Hillman CL; Qing G; Ma AG; Weiss CR; Zhou G; Bai A; Warrington RJ; Bernstein CN; Peng Z
    Mol Med; 2011; 17(7-8):646-56. PubMed ID: 21424108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis.
    van der Marel S; Majowicz A; Kwikkers K; van Logtenstein R; te Velde AA; De Groot AS; Meijer SL; van Deventer SJ; Petry H; Hommes DW; Ferreira V
    World J Gastroenterol; 2012 Aug; 18(32):4288-99. PubMed ID: 22969191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells.
    Palmen MJ; Wijburg OL; Kunst IH; Kroes H; van Rees EP
    Clin Exp Immunol; 1998 May; 112(2):216-25. PubMed ID: 9649183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation.
    Kitani A; Fuss IJ; Nakamura K; Schwartz OM; Usui T; Strober W
    J Exp Med; 2000 Jul; 192(1):41-52. PubMed ID: 10880525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice.
    Katchar K; Kelly CP; Keates S; O'brien MJ; Keates AC
    Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1263-71. PubMed ID: 17272517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.